디지털 병리학 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global Digital Pathology Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Digital Pathology Market Size (2024E): USD 8.05 Bn
• Projected Market Value (2031F): USD 17.2 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 13.5%

Digital Pathology Market - Report Scope:

Digital pathology refers to the acquisition, management, sharing, and interpretation of pathology information in a digital environment. The market includes various products and services, such as digital pathology equipment, software, and services, that enable the transformation of traditional microscopy and pathology workflows. The growing adoption of digital pathology solutions is driven by factors such as the increasing demand for accurate diagnostics, advancements in telepathology, and the need for efficient and scalable pathology systems in clinical, research, and pharmaceutical settings.

Market Growth Drivers:

The global digital pathology market is driven by several key factors, including advancements in imaging technology, the increasing prevalence of chronic diseases, and the growing adoption of telemedicine and remote diagnostics. Digital pathology solutions provide faster, more accurate, and more efficient diagnostic processes, enabling healthcare providers to improve patient outcomes. The integration of artificial intelligence (AI) and machine learning (ML) in digital pathology systems is enhancing diagnostic accuracy and workflow efficiency. Additionally, increasing investments in digital health technologies and the demand for improved healthcare infrastructure are fueling market growth.

Market Restraints:

Despite its promising growth, the digital pathology market faces challenges such as high initial investment costs for equipment, integration complexities with existing healthcare systems, and concerns about data privacy and security. Additionally, the adoption of digital pathology solutions in developing regions is hindered by limited access to advanced healthcare technologies and a lack of skilled professionals. These barriers need to be addressed to unlock the full potential of digital pathology solutions in global markets.

Market Opportunities:

The market presents significant growth opportunities driven by advancements in technology, increased healthcare spending, and the expansion of personalized medicine. The integration of cloud-based platforms, AI-driven diagnostics, and improved imaging techniques offers new avenues for growth. Moreover, the rising demand for molecular diagnostics, drug development, and research applications presents substantial opportunities for digital pathology solutions. Collaborations between key market players, research institutes, and healthcare providers will play a crucial role in advancing the adoption of digital pathology technologies.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the digital pathology market?
• Which types of digital pathology products are witnessing the highest adoption across different regions?
• How is the integration of AI and machine learning transforming the digital pathology landscape?
• Who are the leading players in the digital pathology market, and what strategies are they employing to remain competitive?
• What are the emerging trends and future prospects in the digital pathology market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital pathology market, such as Danaher Corporation, F. Hoffmann-La Roche AG, and Koninklijke Philips N.V., are focusing on product innovation, strategic partnerships, and acquisitions to maintain their market leadership. These companies are investing heavily in research and development to create advanced digital pathology solutions that integrate AI, machine learning, and cloud technologies. Collaboration with healthcare providers, research institutes, and regulatory bodies is essential for market expansion and adoption. Furthermore, improving the interoperability of digital pathology systems with existing healthcare IT infrastructure is a key strategy for long-term growth.

Key Companies Profiled:

• Danaher Corporation
• F. Hoffmann-La Roche AG
• Huron Technologies International Inc.
• Koninklijke Philips N.V.
• Olympus Corporation
• Hamamatsu Photonics K.K.
• Carl Zeiss AG
• Nikon Corporation
• 3DHISTECH Ltd.
• Hologic Inc.
• PerkinElmer, Inc.
• Visiopharm

Digital Pathology Industry Research by Category:

By Product Type:

• Digital Pathology Equipment
• Digital Pathology Software
• Digital Pathology Services

By Application:

• Clinical Pathology
• Molecular Diagnostics
• Basic and Applied Research
• Drug Development
• Others

By End User:

• Hospitals
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Forensic Laboratories
• Research Institutes
• Contract Research Organizations (CROs)
• Clinics

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• The Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Digital Pathology Market Snapshot, 2024 - 2031
• 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Analysis
• 3.7. Parent Market Analysis

4. Price Analysis, 2023A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product
• 4.4. Regional Prices and Product Preferences

5. Global Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Bn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
  • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
• 5.3. Global Digital Pathology Market Outlook: Product
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2023
  • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 5.3.3.1. Digital Pathology Equipment
      • 5.3.3.1.1. Whole Slide Scanners
      • 5.3.3.1.1.1. Brightfield Slide Scanners
      • 5.3.3.1.1.2. Fluorescence Slide Scanners
      • 5.3.3.1.1.3. Combination Slide Scanners
      • 5.3.3.1.2. Clinical Microscope
      • 5.3.3.1.3. Tissue Microarrays
    • 5.3.3.2. Digital Pathology Software
      • 5.3.3.2.1. Image Viewing and Analysis Software
      • 5.3.3.2.2. Digital Pathology Information Systems
  • 5.3.4. Market Attractiveness Analysis: Product
• 5.4. Global Digital Pathology Market Outlook: Application
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
  • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 5.4.3.1. Clinical Pathology
    • 5.4.3.2. Molecular Diagnostics
    • 5.4.3.3. Basic & Applied Research
    • 5.4.3.4. Drug Development
    • 5.4.3.5. Others
  • 5.4.4. Market Attractiveness Analysis: Application
• 5.5. Global Digital Pathology Market Outlook: End User
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
  • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 5.5.3.1. Hospitals
    • 5.5.3.2. Diagnostic Laboratories
    • 5.5.3.3. Pharmaceutical & Biotechnology Companies
    • 5.5.3.4. Forensic Laboratories
    • 5.5.3.5. Research Institutes
    • 5.5.3.6. Contract Research Organizations (CROs)
    • 5.5.3.7. Clinics
  • 5.5.4. Market Attractiveness Analysis: End User

6. Global Digital Pathology Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 7.4.1. Digital Pathology Equipment
    • 7.4.1.1. Whole Slide Scanners
      • 7.4.1.1.1. Brightfield Slide Scanners
      • 7.4.1.1.2. Fluorescence Slide Scanners
      • 7.4.1.1.3. Combination Slide Scanners
    • 7.4.1.2. Clinical Microscope
    • 7.4.1.3. Tissue Microarrays
  • 7.4.2. Digital Pathology Software
    • 7.4.2.1. Image Viewing and Analysis Software
    • 7.4.2.2. Digital Pathology Information Systems
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 7.5.1. Clinical Pathology
  • 7.5.2. Molecular Diagnostics
  • 7.5.3. Basic & Applied Research
  • 7.5.4. Drug Development
  • 7.5.5. Others
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 7.6.1. Hospitals
  • 7.6.2. Diagnostic Laboratories
  • 7.6.3. Pharmaceutical & Biotechnology Companies
  • 7.6.4. Forensic Laboratories
  • 7.6.5. Research Institutes
  • 7.6.6. Contract Research Organizations (CROs)
  • 7.6.7. Clinics
• 7.7. Market Attractiveness Analysis

8. Europe Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 8.4.1. Digital Pathology Equipment
    • 8.4.1.1. Whole Slide Scanners
      • 8.4.1.1.1. Brightfield Slide Scanners
      • 8.4.1.1.2. Fluorescence Slide Scanners
      • 8.4.1.1.3. Combination Slide Scanners
    • 8.4.1.2. Clinical Microscope
    • 8.4.1.3. Tissue Microarrays
  • 8.4.2. Digital Pathology Software
    • 8.4.2.1. Image Viewing and Analysis Software
    • 8.4.2.2. Digital Pathology Information Systems
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 8.5.1. Clinical Pathology
  • 8.5.2. Molecular Diagnostics
  • 8.5.3. Basic & Applied Research
  • 8.5.4. Drug Development
  • 8.5.5. Others
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 8.6.1. Hospitals
  • 8.6.2. Diagnostic Laboratories
  • 8.6.3. Pharmaceutical & Biotechnology Companies
  • 8.6.4. Forensic Laboratories
  • 8.6.5. Research Institutes
  • 8.6.6. Contract Research Organizations (CROs)
  • 8.6.7. Clinics
• 8.7. Market Attractiveness Analysis

9. East Asia Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 9.4.1. Digital Pathology Equipment
    • 9.4.1.1. Whole Slide Scanners
      • 9.4.1.1.1. Brightfield Slide Scanners
      • 9.4.1.1.2. Fluorescence Slide Scanners
      • 9.4.1.1.3. Combination Slide Scanners
    • 9.4.1.2. Clinical Microscope
    • 9.4.1.3. Tissue Microarrays
  • 9.4.2. Digital Pathology Software
    • 9.4.2.1. Image Viewing and Analysis Software
    • 9.4.2.2. Digital Pathology Information Systems
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 9.5.1. Clinical Pathology
  • 9.5.2. Molecular Diagnostics
  • 9.5.3. Basic & Applied Research
  • 9.5.4. Drug Development
  • 9.5.5. Others
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 9.6.1. Hospitals
  • 9.6.2. Diagnostic Laboratories
  • 9.6.3. Pharmaceutical & Biotechnology Companies
  • 9.6.4. Forensic Laboratories
  • 9.6.5. Research Institutes
  • 9.6.6. Contract Research Organizations (CROs)
  • 9.6.7. Clinics
• 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 10.4.1. Digital Pathology Equipment
    • 10.4.1.1. Whole Slide Scanners
      • 10.4.1.1.1. Brightfield Slide Scanners
      • 10.4.1.1.2. Fluorescence Slide Scanners
      • 10.4.1.1.3. Combination Slide Scanners
    • 10.4.1.2. Clinical Microscope
    • 10.4.1.3. Tissue Microarrays
  • 10.4.2. Digital Pathology Software
    • 10.4.2.1. Image Viewing and Analysis Software
    • 10.4.2.2. Digital Pathology Information Systems
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 10.5.1. Clinical Pathology
  • 10.5.2. Molecular Diagnostics
  • 10.5.3. Basic & Applied Research
  • 10.5.4. Drug Development
  • 10.5.5. Others
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 10.6.1. Hospitals
  • 10.6.2. Diagnostic Laboratories
  • 10.6.3. Pharmaceutical & Biotechnology Companies
  • 10.6.4. Forensic Laboratories
  • 10.6.5. Research Institutes
  • 10.6.6. Contract Research Organizations (CROs)
  • 10.6.7. Clinics
• 10.7. Market Attractiveness Analysis

11. Latin America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Application
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 11.4.1. Digital Pathology Equipment
    • 11.4.1.1. Whole Slide Scanners
      • 11.4.1.1.1. Brightfield Slide Scanners
      • 11.4.1.1.2. Fluorescence Slide Scanners
      • 11.4.1.1.3. Combination Slide Scanners
    • 11.4.1.2. Clinical Microscope
    • 11.4.1.3. Tissue Microarrays
  • 11.4.2. Digital Pathology Software
    • 11.4.2.1. Image Viewing and Analysis Software
    • 11.4.2.2. Digital Pathology Information Systems
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 11.5.1. Clinical Pathology
  • 11.5.2. Molecular Diagnostics
  • 11.5.3. Basic & Applied Research
  • 11.5.4. Drug Development
  • 11.5.5. Others
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 11.6.1. Hospitals
  • 11.6.2. Diagnostic Laboratories
  • 11.6.3. Pharmaceutical & Biotechnology Companies
  • 11.6.4. Forensic Laboratories
  • 11.6.5. Research Institutes
  • 11.6.6. Contract Research Organizations (CROs)
  • 11.6.7. Clinics
• 11.7. Market Attractiveness Analysis

12. Middle East & Africa Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 12.2.1. By Country
  • 12.2.2. By Product
  • 12.2.3. By Application
  • 12.2.4. By End User
• 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 12.4.1. Digital Pathology Equipment
    • 12.4.1.1. Whole Slide Scanners
      • 12.4.1.1.1. Brightfield Slide Scanners
      • 12.4.1.1.2. Fluorescence Slide Scanners
      • 12.4.1.1.3. Combination Slide Scanners
    • 12.4.1.2. Clinical Microscope
    • 12.4.1.3. Tissue Microarrays
  • 12.4.2. Digital Pathology Software
    • 12.4.2.1. Image Viewing and Analysis Software
    • 12.4.2.2. Digital Pathology Information Systems
• 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 12.5.1. Clinical Pathology
  • 12.5.2. Molecular Diagnostics
  • 12.5.3. Basic & Applied Research
  • 12.5.4. Drug Development
  • 12.5.5. Others
• 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 12.6.1. Hospitals
  • 12.6.2. Diagnostic Laboratories
  • 12.6.3. Pharmaceutical & Biotechnology Companies
  • 12.6.4. Forensic Laboratories
  • 12.6.5. Research Institutes
  • 12.6.6. Contract Research Organizations (CROs)
  • 12.6.7. Clinics
• 12.7. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Leica Biosystems (Danaher Corporation)
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Products
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. F. Hoffmann-La Roche AG
  • 13.3.3. Huron Technologies International Inc.
  • 13.3.4. Koninklijke Philips N.V.
  • 13.3.5. Olympus Corporation
  • 13.3.6. Hamamatsu Photonics K.K.
  • 13.3.7. Carl Zeiss AG
  • 13.3.8. Nikon Corporation
  • 13.3.9. 3DHISTECH Ltd.
  • 13.3.10. Hologic Inc.
  • 13.3.11. PerkinElmer, Inc.
  • 13.3.12. Visiopharm
  • 13.3.13. OptraSCAN, Inc.
  • 13.3.14. Inspirata, Inc.

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations